Market Exclusive

Analyst Activity – Jefferies Group Initiates Coverage On Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR) With a Buy

Analyst Ratings For Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR)

Today, Jefferies Group initiated coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR) with a Buy with a price target of $10.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR)
Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR) has insider ownership of 4.60% and institutional ownership of 26.88%.

Recent Trading Activity for Arrowhead Pharmaceuticals (NASDAQ:ARWR) (NASDAQ:ARWR)
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) closed the previous trading session at 7.71 up +0.77 11.10% with 458980 shares trading hands.

Exit mobile version